Xerostomia Therapeutic Market Report: Trends, Forecast and Competitive Analysis to 2030

Xerostomia Therapeutic Trends and Forecast

The future of the global xerostomia therapeutic market looks promising with opportunities in the over the counter and prescription applications. The global xerostomia therapeutic market is expected to reach an estimated $1.1 billion by 2030 with a CAGR of 3.5% from 2024 to 2030. The major drivers for this market are growing demand for xerostomia treatments, rising development of new and innovative xerostomia treatments, and increasing awareness of xerostomia.

A more than 150-page report is developed to help in your business decisions.

Xerostomia Therapeutic by Segment

The study includes a forecast for the global xerostomia therapeutic by product type, application, and region.

Xerostomia Therapeutic Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

• Artificial Saliva
• Dentifrices
• Salivary Stimulants
• Saliva Substitutes
• Drugs
• Salivary Pen

Xerostomia Therapeutic Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Over The Counter
• Prescription

Xerostomia Therapeutic Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Xerostomia Therapeutic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies xerostomia therapeutic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the xerostomia therapeutic companies profiled in this report include-

• GlaxoSmithKline
• Church & Dwight
• Colgate-Palmolive
• Hikma Pharmaceuticals
• Pendopharm
• Sun Pharmaceuticals
• Lupin Pharmaceuticals
• Pfizer
• Parnell Pharmaceuticals
• Acacia Pharma

Xerostomia Therapeutic Market Insights

Lucintel forecasts that artificial saliva is expected to witness highest growth over the forecast period due to its significant usage to perform similarly to natural saliva.

North America is expected to witness highest growth over the forecast period due to the growing cases of dry mouth among population and availability of advanced treatment options in the region.

Features of the Global Xerostomia Therapeutic Market

Market Size Estimates: Xerostomia therapeutic market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Xerostomia therapeutic market size by product type, application, and region in terms of value ($B).

Regional Analysis: Xerostomia therapeutic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, applications, and regions for the xerostomia therapeutic market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the xerostomia therapeutic market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the xerostomia therapeutic market size?

Answer: The global xerostomia therapeutic market is expected to reach an estimated $1.1 billion by 2030.

Q.2 What is the growth forecast for xerostomia therapeutic market?

Answer: The global xerostomia therapeutic market is expected to grow with a CAGR of 3.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the xerostomia therapeutic market?

Answer: The major drivers for this market are growing demand for xerostomia treatments, rising development of new and innovative xerostomia treatments, and increasing awareness of xerostomia.

Q4. What are the major segments for xerostomia therapeutic market?

Answer: The future of the xerostomia therapeutic market looks promising with opportunities in the over the counter and prescription applications.

Q5. Who are the key xerostomia therapeutic market companies?

Answer: Some of the key xerostomia therapeutic companies are as follows:

• GlaxoSmithKline
• Church & Dwight
• Colgate-Palmolive
• Hikma Pharmaceuticals
• Pendopharm
• Sun Pharmaceuticals
• Lupin Pharmaceuticals
• Pfizer
• Parnell Pharmaceuticals
• Acacia Pharma

Q6. Which xerostomia therapeutic market segment will be the largest in future?

Answer: Lucintel forecasts that artificial saliva is expected to witness highest growth over the forecast period due to its significant usage to perform similarly to natural saliva.

Q7. In xerostomia therapeutic market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to the growing cases of dry mouth among population and availability of advanced treatment options in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the xerostomia therapeutic market by product type (artificial saliva, dentifrices, salivary stimulants, saliva substitutes, drugs, and salivary pen), application (over the counter and prescription), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?